The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Radiotherapy, atezolizumab, and bevacizumab in rectal cancers with the aim of organ preservation: The TARZAN study.
 
Yara L. Verschoor
No Relationships to Disclose
 
Doenja M. J. Lambregts
No Relationships to Disclose
 
José van den Berg
No Relationships to Disclose
 
Brechtje A. Grotenhuis
No Relationships to Disclose
 
Arend Aalbers
No Relationships to Disclose
 
Baukelien Van Triest
No Relationships to Disclose
 
Regina G.H. Beets-Tan
No Relationships to Disclose
 
Marieke van de Belt
No Relationships to Disclose
 
Simone Dokter
No Relationships to Disclose
 
Sara Balduzzi
No Relationships to Disclose
 
Emile E. Voest
Consulting or Advisory Role - Aglaia BioMedical Ventures (Inst); Biogeneration Ventures; InteRNA; Life Sciences Partners (Inst); Roche Pharma AG (Inst); Servier (Inst)
Research Funding - AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Eisai (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Lilly (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen (Inst)
 
John B. A. G. Haanen
Stock and Other Ownership Interests - Neogene Therapeutics
Consulting or Advisory Role - Achilles Therapeutics (Inst); bioNTech (Inst); Bristol-Myers Squibb (Inst); Immunocore (Inst); Instil Bio (Inst); Iovance Biotherapeutics (Inst); Ipsen (Inst); Molecular Partners (Inst); MSD Oncology (Inst); Neogene Therapeutics; Novartis (Inst); Pfizer (Inst); POEM Health (Inst); Roche/Genentech (Inst); Sanofi (Inst); T-Knife (Inst); Third Rock Ventures (Inst)
Research Funding - Amgen (Inst); Asher Biotherapeutics (Inst); BioNTech (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Neon Therapeutics (Inst); Novartis (Inst)
 
Monique E. van Leerdam
No Relationships to Disclose
 
Geerard Beets
No Relationships to Disclose
 
Myriam Chalabi
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); Numab (Inst)
Research Funding - Bristol-Myers Squibb (Inst); MSD (Inst); Roche (Inst)